Impact of the 2017 ACC/AHA hypertension guidelines on antihypertensive prescribing in the United States: real-world evidence from a nationally representative population
After the 2017 ACC/AHA guidelines update, antihypertensive prescribing in the US showed increased use of ARBs and CCBs. However, declining FDC use highlights a persistent gap between evidence-based guidance and real-world practice.
Authors
- Eissa A. Jafari
Institutions
- Jazan University (SA)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-02-25
- DOI
- https://doi.org/10.3389/fphar.2026.1787466
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Agency for Healthcare Research and Quality